Alirocumab (Mammifere/Hamster/Cellules Cho) shortage status
No active shortage currently reported by the regulators Mederti tracks — 1 anticipated notice on file.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Alirocumab (Mammifere/Hamster/Cellules Cho)
- Brand names
- Praluent
- ATC code
- C10AX14
- Class
- Auto-created by Agence nationale de sécurité du médicament — Disponibilité scraper
Frequently asked questions
Is Alirocumab (Mammifere/Hamster/Cellules Cho) currently in shortage?
No active shortage of Alirocumab (Mammifere/Hamster/Cellules Cho) is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Alirocumab (Mammifere/Hamster/Cellules Cho) shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Related medicines
Simvastatin · Atorvastatin 80 Mg Film-Coated Tablets (Atorvastatin) · Atorvastatin Calcium Tablet · Atorvastatin Calcium Tablet Usp · Atorvastatin Calcium Tablets · Atorvastatin Calcium Tablets Usp
Get alerted when Alirocumab (Mammifere/Hamster/Cellules Cho) status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.